ArticleInternational journal of radiation oncology, biology, physics2025
Space- and Time-Defined Monte Carlo Dosimetry Explains Ovarian Cancer Cell Viability in Targeted α-Particle Therapy With Astatine 211-ParaThanatrace.
Article in International journal of radiation oncology, biology, physics, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
2 citing papers in PubMed.
- Monte Carlo microdosimetry ofEJNMMI physics · 2026Article
- An analytical framework for efficient and precision-controlled Monte Carlo simulation of heterogeneous targeted alpha therapy microdosimetry.Medical physics · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
8 authors.
Funding
Abstract
purposeRadiopharmaceutical therapy (RPT) aims to irradiate tumors using antibodies or small molecules chelated with radioisotopes that target tumor cells. The biological response resulting from the complex interplay between radioisotope decay and cell binding processes is not yet fully understood. Because dose, including its spatiotemporal pattern, strongly correlates with ionizing radiation effects, detailed dosimetry is essential to predict biological responses. This study introduces TOol for PArticle Simulation (TOPAS)-RPT, a Monte Carlo platform for stochastic and spatiotemporal heterogeneous radiation exposures that models the interplay of radioisotope decay and radioligand-receptor binding. METHODS AND MATERIALS: We implemented new models within the TOPAS Monte Carlo platform to enable the dynamic simulation of RPT exposures. Simulations were discretized over time in a series of independent runs. Binding kinetics were implemented using a compartmental model with dynamic populations, updating the abundance and distribution of the isotopes at every time step. In this work, TOPAS-RPT was applied to replicate in vitro viability experiments on ovarian cancer cells (SKOV3 and PEO1) treated under different conditions with astatine 211-ParaThanatrace ([
resultsWe used the proposed TOPAS-RPT to perform a dose-viability analysis. In PEO1 cells, we observed a consistent dose-viability response when cells were exposed to [
conclusionsThe characterized time- and space-structure of the absorbed dose needs to be accounted for to explain variabilities in radiosensitivity to RPT exposures with diverse binding properties and radiation emissions.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.